<DOC>
	<DOCNO>NCT02070913</DOCNO>
	<brief_summary>A single-center , prospective case series clinical study consecutively enrol 10 patient expect duration 12 month less . The study objective evaluate retention feasibility integrate therapeutic hypothermia use ZOLL IVTM System .</brief_summary>
	<brief_title>COOL-AMI EU Case Series Clinical Study</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Hypothermia</mesh_term>
	<criteria>The patient 18 year age . The patient must symptoms consistent AMI MI STsegment elevation The patient eligible PCI . The expected timing treatment pathway patient allow least 10 minute cool IVTM System prior PCI . The patient patient legal representative willing provide write , inform consent participate clinical study . The patient previous myocardial infarction The patient experience cardiogenic shock The patient experience acute pulmonary edema . The patient present cardiac arrest . The patient present Killip risk stratification class II IV . The patient present Atrial Fibrillation . The patient history prior large myocardial infarct infarct segment currently affect . The patient require immediate surgical procedural intervention PCI The patient aortic dissection . The patient hepatic failure . The patient end stage kidney disease . The patient febrile Known chronic Congestive Heart Failure ( CHF ) . Known previous CABG . Known recent stroke Cardiopulmonary decompensation occur en route hospital Contraindications hypothermia The patient know hypersensitivity contraindication aspirin , heparin , sensitivity contrast medium , adequately premedicated . The patient known history coagulopathy The patient know pregnant The patient know hypersensitivity antishivering medication . Patient known history severe hepatic renal impairment . The patient Inferior Vena Cava filter place ( IVC ) . The patient life expectancy le 1 year The patient know , unresolved history drug use The patient currently enrol another investigational drug device trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Hypothermia</keyword>
	<keyword>Acute Myocardial Infarction</keyword>
	<keyword>Percutaneous Coronary Intervention</keyword>
	<keyword>AMI</keyword>
	<keyword>PCI</keyword>
	<keyword>Therapeutic Hypothermia</keyword>
</DOC>